Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Objective Insulin resistance and nonalcoholic fatty liver disease have been linked to several lipid metabolites in animals, but their role in humans remains unclear. This study examined the relationship of sphingolipids with hepatic and peripheral metabolism in 21 insulin-resistant obese patients without (NAFL-) or with (NAFL+) nonalcoholic fatty liver and nonalcoholic steatohepatitis (NASH) and 7 healthy lean individuals undergoing tissue biopsies during bariatric or elective abdominal surgery. Research design and methods Hyperinsulinemic-euglycemic clamps with d-[6,6- 2 H 2 ]glucose were performed to quantify tissue-specific insulin sensitivity. Hepatic oxidative capacity, lipid peroxidation, and the phosphorylated-to-total c-Jun N-terminal kinase (pJNK-to-tJNK) ratio were measured to assess mitochondrial function, oxidative stress, and inflammatory activity. Results Hepatic total ceramides were higher by 50% and 33% in NASH compared with NAFL+ and NAFL-, respectively. Only in NASH were hepatic dihydroceramides (16:0, 22:0, and 24:1) and lactosylceramides increased. Serum total ceramides and dihydroceramides (hepatic dihydroceramides 22:0 and 24:1) correlated negatively with whole-body but not with hepatic insulin sensitivity. Hepatic maximal respiration related positively to serum lactosylceramide subspecies, hepatic sphinganine, and lactosylceramide 14:0. Liver lipid peroxides (total ceramides, sphingomyelin 22:0) and the pJNK-to-tJNK ratio (ceramide 24:0; hexosylceramide…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With increasing hepatic lipid accumulation, the generation of toxic lipid intermediates (diacylglycerols, ceramides) and altered hepatic mitochondrial respiration rates drive hepatic insulin resistance, inflammation and oxidative stress -all of them fueling pro-fibrotic pathways (Fig. 1) [26,27].”
From Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease? (2024) · cites this paper as [27]
In the citing paper
“Patients with MASH have 20% higher ceramide concentrations compared to healthy individuals.100,102,104,117”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [100]
In the citing paper
“High levels of plasma ceramides are correlated with the severity of MASLD and reflect hepatic ceramide accumulation.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [100]
In the citing paper
“Ceramides are among the most studied lipids because of their lipotoxic activity in several organs and have been reported to be increased in the plasma of patients with MASLD.94,[99], [100], [101], [102],[107], [108], [109],115”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [100]
In the citing paper
“Among ceramides, in a small cohort of seven patients, Apostolopoulou et al.100 showed that total ceramides, as well as lactosyl-, hexosyl-, and dihydro-ceramides were significantly increased in MASH”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [100]
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Sphingolipid metabolites in inflammatory disease
Maceyka, M., & Spiegel, S. (2014) · Nature · doi:10.1038/nature13475 · Cited by 1,277 · cited 3×
“HDL-cholesterol (mg/dL) 64 (57, 83)¶,# 44 (35, 54) 35 (33,45) 52 (43, 59)”
BackgroundKoliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032
Self-citationTilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002 · cited 8×
“The NAFL+ group included one participant with T2D.”
BackgroundMethodInfluentialSelf-citationReceptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892 · cited 1×
“Rodent studies using a high-fat diet or in leptin-deficientob/obmicehave shown controversial resultsfortherelationshipof hepatic accumulation of ceramides with hepatic insulin sensitivity (26,27).”
BackgroundSelf-citationSunny, N. E., Parks, E. J., Browning, J. D., & Burgess, S. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.004 · Cited by 672 · cited 2×
“Of note, obese people have increased hepatic mitochondrial capacity (10,11), which declines in nonalcoholicsteatohepatitis (NASH)along”
BackgroundHaus, J. M., Kashyap, S. R., Kasumov, T., Zhang, R., Kelly, K. R., DeFronzo, R. A., & Kirwan, J. P. (2009) · Diabetes · doi:10.2337/db08-1228 · Cited by 663
Ceramides – Lipotoxic Inducers of Metabolic Disorders
Chaurasia, B., & Summers, S. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.07.006 · Cited by 616
The role of mitochondria in insulin resistance and type 2 diabetes mellitus
Szendroedi, J., Phielix, E., & Roden, M. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.138 · Cited by 600
Self-citationCellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Kumashiro, N., Erion, D. M., Zhang, D., Kahn, M., Beddow, S. A., Chu, X., Still, C. D., Gerhard, G. S., Han, X., Dziura, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113359108 · Cited by 585 · cited 1×
“Liver total ceramides did not relate to whole-body insulin sensitivity, extending previous findings using HOMA-insulin resistanceasasurrogateof insulinresistance (5).”
Background
Cited by
Items 101–200 of 287
Johnson, K. A., Endapally, S., Vazquez, D. C., Infante, R. E., & Radhakrishnan, A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010393 · Cited by 39
“Mass spectrometry analysis of sphingomyelin was performed as described previously (41) using a Nexera X2 UHPLC system coupled to a Shimadzu LCMS-8050 triple quadrupole mass spectrometer operating the dual ion source in electrospray negative mode.”
MethodJung, Y., Lee, M. K., Puri, P., Koo, B. K., Joo, S. K., Jang, S. Y., Lee, D. H., Jung, Y. J., Kim, B. G., Lee, K. L., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16066 · Cited by 41
Metabolomics at the cutting edge of risk prediction of MASLD
Tan, E. Y., Muthiah, M. D., & Sanyal, A. J. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101853 · Cited by 50
An Innovative Lipidomic Workflow to Investigate the Lipid Profile in a Cystic Fibrosis Cell Line
Dei, M., Zulueta, A., Mingione, A., Caretti, A., Ghidoni, R., Signorelli, P., & Paroni, R. C. (2020) · Cells · doi:10.3390/cells9051197 · Cited by 38
“In addition, hexosylceramides, which may link either glucose or galactose to ceramide, and lactosylceramides have been associated with oxidative stress and promotion of the inflammatory pathway [53].”
BackgroundTargeted inhibition of hepatic de novo ceramide synthesis ameliorates MASH
Yu, X., Huang, C., Evers, M. J. W., Liu, J., Ting, H. J., Zhang, S., Chong, S. Y., Tan, M. S., Wang, S., Sayed, N., et al. (2025) · Science Advances · doi:10.1126/sciadv.adx2681 · Cited by 37
“…lipids, we observed an increase in various species of ceramides in both patients with MALSD/MASH and across three mouse models of MASH, supporting the notion that increased plasma and hepatic ceramide levels are closely associated with the pathogenesis of MASLD and MASH ( 7 , 8 , 10 – 13 , 22 ).”
Perakakis, N., Chrysafi, P., Feigh, M., Veidal, S. S., & Mantzoros, C. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126332 · Cited by 34
“Hepatic lactosylceramides are elevated in NASH in humans [21] and are considered important contributors to inflammation by regulating cell adhesion/migration pathways [22].”
BackgroundLipidomics analysis reveals new insights into the goose fatty liver formation
Wei, R., Ning, R., Han, C., Wei, S., Teng, Y., Li, L., Liu, H., Hu, S., Kang, B., & Xu, H. (2022) · Poultry Science · doi:10.1016/j.psj.2022.102428 · Cited by 52
“, 2015), as well as dihydroceramides which are basic markers of de novo Cer synthesis (Apostolopoulou et al., 2018).”
BackgroundBalram, A., Thapa, S., & Chatterjee, S. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315442 · Cited by 34
“We have correlated increased levels of LacCer in liver of type II diabetic mice with systemic inflammation involving multiple pro-inflammatory molecules, e.g., IL-6, hs-CRP, TNF-α [17].”
BackgroundLiraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes
Denimal, D., Bergas, V., de Barros, J.-P. P., Simoneau, I., Demizieux, L., Passilly‐Degrace, P., Bouillet, B., Petit, J., Rouland, A., Bataille, A., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01845-0 · Cited by 33
“Clinical studies reveal that circulating DhCer and Cer levels are increased in patients with MAFLD [10, 14], and that they mirror the hepatic content of DhCer and Cer [14].”
BackgroundInfluentialLowering ceramides to overcome diabetes
Kusminski, C. M., & Scherer, P. E. (2019) · Science · doi:10.1126/science.aax6594 · Cited by 33
Self-citationApostolopoulou, M., Gordillo, R., Gancheva, S., Straßburger, K., Herder, C., Esposito, I., Schlensak, M., Scherer, P. E., & Roden, M. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001860 · Cited by 34
Self-citationGao, Y., Qian, M., Wei, Q., Duan, X., Wang, S.-L., Hu, H., Liu, J., Pan, C., Zhang, S.-Q., Qi, L., et al. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0310-0 · Cited by 34
Role of hepatic lipid species in the progression of nonalcoholic fatty liver disease
Deng, K., Huang, X., Lei, F., Zhang, X., Zhang, P., She, Z., Cai, J., Ji, Y., & Li, H. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00123.2022 · Cited by 32
Sekar, R., Motzler, K., Kwon, Y., Novikoff, A., Jülg, J., Najafi, B., Wang, S., Warnke, A.-L., Seitz, S., Hass, D., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.022 · Cited by 32
Self-citationFrom Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria
Amorim, R., Magalhães, C. C., Borges, F., Oliveira, P. J., & Teixeira, J. (2023) · Biology · doi:10.3390/biology12040595 · Cited by 35
“Exacerbated hepatic ceramide content is linked to diminished mitochondrial oxidative capacity [83].”
BackgroundRamos‐Molina, B., Rossell, J., de, A. P.-M., Pardina, E., Genua, I., Rojo-López, M. I., Julián, M. T., Alonso, N., Julve, J., & Mauricio, D. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1400961 · Cited by 32
Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_18 · Cited by 33
Chen, Y., Qian, Q., & Yu, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108868 · Cited by 31
Cordyceps inhibits ceramide biosynthesis and improves insulin resistance and hepatic steatosis
Li, Y., Talbot, C. L., Chandravanshi, B., Ksiazek, A., Sood, A., Chowdhury, K. H., Maschek, J. A., Cox, J. E., Babu, A. K. S., Paz, H. A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-11219-3 · Cited by 30
Wang, H., Chen, Z., Wang, M., Long, M., Ren, T., Chen, C., Dai, X., Yang, S., & Tan, S. (2022) · Foods · doi:10.3390/foods11121747 · Cited by 31
“Preventing the accumulation of ceramides can prevent insulin resistance, cardiovascular diseases, and hepatic steatosis [31,32].”
BackgroundChronic kidney disease in a murine model of non-alcoholic steatohepatitis (NASH)
Li, X., Bhattacharya, D., Yuan, Y., Wei, C., Zhong, F., Ding, F., D’Agati, V. D., Lee, K., Friedman, S. L., & He, C. (2023) · Kidney International · doi:10.1016/j.kint.2023.12.009 · Cited by 31
Jiang, H., Jin, J., Duan, Y., Xie, Z., Li, Y., Gao, A., Gu, M., Zhang, X., Peng, C. S., Xia, C., et al. (2019) · Diabetes · doi:10.2337/db19-0589 · Cited by 30
Haberl, E. M., Pohl, R., Rein‐Fischboeck, L., Höring, M., Krautbauer, S., Liebisch, G., & Buechler, C. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01425-1 · Cited by 30
“NASH liver, and a separate study reported an increase of Cer d18:1/16:0 whereas Cer d18:1/24:0 declined [35, 36].”
BackgroundSun, C., Guo, Y., Cong, P., Tian, Y., & Gao, X. (2023) · Nutrients · doi:10.3390/nu15061359 · Cited by 28
“Sphingolipid metabolism is involved in NAFLD development in several ways [55,56].”
BackgroundMucinski, J. M., Manrique‐Acevedo, C., Kasumov, T., Garrett, T. J., Gaballah, A., & Parks, E. J. (2020) · Lipids · doi:10.1002/lipd.12244 · Cited by 27
KAHL, S., Straßburger, K., Pacini, G., Trinks, N., Pafili, K., Mastrototaro, L., Dewidar, B., Sarabhai, T., Trenkamp, S., Esposito, I., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.08.012 · Cited by 30
Self-citationL-Selectin/CD62L Is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and Men
Drescher, H. K., Schippers, A., Rosenhain, S., Gremse, F., Bongiovanni, L., de Bruin, A., Eswaran, S., Gallage, S., Pfister, D. R., Szydlowska, M., et al. (2020) · Cells · doi:10.3390/cells9051106 · Cited by 29
“The important role of oxidative stress caused by toxic lipids and the anti-oxidative stress response during insulin resistance, metabolic disorders, and steatohepatitis development is widely accepted [64].”
BackgroundKim, J. S., Ramachandran, R., & Wierzbicki, A. S. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000704 · Cited by 30
“Liver lipid peroxides correlated with the respective hepatic sphingolipids [39].”
BackgroundDeVeaux, S. A., Ogle, M. E., Vyshnya, S., Chiappa, N. F., Leitmann, B., Rudy, R., Day, A., Mortensen, L. J., Kurtzberg, J., Roy, K., et al. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2021.12.009 · Cited by 27
Associations of NAFLD with circulating ceramides and impaired glycemia
Gadgil, M. D., Sarkar, M. A., Sands, C. J., Lewis, M. R., Herrington, D. M., & Kanaya, A. M. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109829 · Cited by 27
Structural basis of the mechanism and inhibition of a human ceramide synthase
Pascoa, T. C., Pike, A. C. W., Tautermann, C. S., Chi, G., Traub, M., Quigley, A., Chalk, R., Štefanić, S., Thamm, S., Pautsch, A., et al. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01414-3 · Cited by 25
“Abnormal ceramide accumulation is associated with metabolic dysfunction and elevated levels of ceramides have been observed in obesity-related metabolic disorders such as diabetes, nonalcoholic fatty liver disease and non-alcoholic steatohepatitis (NASH) 2–4 .”
Role of dietary and nutritional interventions in ceramide-associated diseases
Wang, S., Jin, Z., Wu, B., Morris, A. J., & Deng, P. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100726 · Cited by 27
Targeting mineralocorticoid receptors in diet-induced hepatic steatosis and insulin resistance
Habibi, J., Chen, D., Hulse, J. L., Whaley‐Connell, A. T., Sowers, J. R., & Jia, G. (2022) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00316.2021 · Cited by 26
Mesenchymal stem cells-based therapy in liver diseases
Han, H., Jin, W., & Li, X. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00088-x · Cited by 25
Holland, W. L., & Summers, S. A. (2018) · Diabetes · doi:10.2337/dbi18-0018 · Cited by 25
“Alternatively, hepatic ceramides may be more tightly linked with progression to nonalcoholic steatohepatitis, with plasma ceramides serving as a predictive biomarker in progression of the disease (17).”
BackgroundEffects on the liver lipidome of rat offspring prenatally exposed to bisphenol A
Nguyen, H. T., Li, L., Eguchi, A., Kannan, K., Kim, E., & Iwata, H. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143466 · Cited by 24
Xu, Y., Li, H., Han, Y., Wang, T., Wang, Y., Gong, J., Gao, K., Wu, C., Li, W., Zhang, H., et al. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03853-z · Cited by 24
“1 3 associated with decreased insulin sensitivity, as indicated by HOMA-IR and the M value [37, 38].”
BackgroundCeramide Content in Liver Increases Along with Insulin Resistance in Obese Patients
Hady, H. R., Błachnio-Zabielska, A. U., Szczerbiński, Ł., Zabielski, P., Imierska, M., Dadan, J., & Kretowski, A. J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122197 · Cited by 26
“, performed on obese subjects with various stages of NAFLD or steatohepatitis, did not show considerable alternations in individual liver ceramides [42].”
Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation
Sharma, S. K., Prathigudupu, V., Cable, C., Serrano, L. R., Nerella, S., Chen, A., Hassan, G., Lakins, J. N., Lizama, C. O., Tsukui, T., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.ads9470 · Cited by 25
Park, S., Lee, J. J., Lee, S. M., Lee, J., Seo, C., Hwang, G., & Jung, J. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112999 · Cited by 23
LRRK2 Regulates CPT1A to Promote β-Oxidation in HepG2 Cells
Lin, C.-W., Peng, Y., Lin, Y., Mersmann, H. J., & Ding, S. (2020) · Molecules · doi:10.3390/molecules25184122 · Cited by 24
“associated with oxidative stress and inflammation that is increased in the livers of NASH patients [64].”
BackgroundEffting, P. S., Thirupathi, A., Muller, A. P., Pereira, B. D. C., Sepa-Kishi, D. M., Marqueze, L. F., Vasconcellos, F. F., Nesi, R. T., Pereira, T. C. B., Kist, L. W., et al. (2022) · Nutrients · doi:10.3390/nu14112179 · Cited by 25
Babiy, B., Ramos‐Molina, B., Ocaña, L., Sacristán, S., Burgos‐Santamaría, D., Martínez-Botas, J., Busto, R., Busto, R., Frutos, M. D., Albillos, A., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159318 · Cited by 25
Surugihalli, C., Porter, T. E., Chan, A., Farley, L. S., Maguire, M., Zhang, C., Kattapuram, N., Muyyarikkandy, M. S., Liu, H., & Sunny, N. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-56715-1 · Cited by 26
Muralidharan, S., Lee, J. W. J., Lim, Y. S., Muthiah, M. D., Tan, E., Demicioglu, D., Shabbir, A., Loo, W. M., Koo, C. S., Lee, Y. M., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156063 · Cited by 22
Ma, Z., Zhang, J., Kang, X., Xu, C., Sun, C., Tao, L., Zheng, D., Han, Y., Li, Q., Guo, X., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.08.006 · Cited by 22
Faquih, T. O., van Klinken, J. B., Li‐Gao, R., Noordam, R., van Heemst, D., Boone, S. C., Sheridan, P. A., Michelotti, G. A., Lamb, H. J., de Mutsert, R., et al. (2023) · Liver International · doi:10.1111/liv.15575 · Cited by 21
DES1: A Key Driver of Lipotoxicity in Metabolic Disease
Blitzer, J. T., Wang, L., & Summers, S. A. (2020) · DNA and Cell Biology · doi:10.1089/dna.2020.5402 · Cited by 21
“Genetic ablation or pharmacological inhibition of various enzymatic steps in the de novo pathway of ceramide biosynthesis yields robust disease-modification in industrystandard animal models of insulin resistance/T2D and NAFLD/ NASH (Holland et al., 2007, 2011; Ussher et al., 2010; Bikman et al., 2012; Zhang et al., 2…”
BackgroundInfluentialWang, M., He, Y., Zhao, Y., Zhang, L., Liu, J., Zheng, S., & Bai, Y. (2024) · Environmental Geochemistry and Health · doi:10.1007/s10653-023-01794-3 · Cited by 19
“For PM 2.5 chemical components, it should be noted that BC is related to the onset of diabetes by inducing inflammation, hepatic oxidative stress, functional damage to β-cells and insulin resistance (Apostolopoulou et al., 2018; Bourdon et al., 2012).”
InfluentialAdvances in paediatric nonalcoholic fatty liver disease: Role of lipidomics
Sessa, A. D., Riccio, S., Pirozzi, E., Verde, M., Passaro, A. P., Umano, G. R., Guarino, S., del Giudice, E. M., & Marzuillo, P. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i25.3815 · Cited by 20
Charytoniuk, T., Harasim‐Symbor, E., Polak, A., Drygalski, K., Berk, K., Chabowski, A., & Konstantynowicz-Nowicka, K. (2018) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666181224161255 · Cited by 18
Wei, T., Tan, D., Zhong, S., Zhang, H., Deng, Z., & Li, J. (2023) · Food & Function · doi:10.1039/d3fo00723e · Cited by 18
Extracellular Vesicles in Hepatobiliary Health and Disease
Parthasarathy, G., Hirsova, P., Kostallari, E., Sidhu, G. S., Ibrahim, S. H., & Malhi, H. (2023) · Comprehensive physiology · doi:10.1002/cphy.c210046 · Cited by 18
Xu, C., Song, D., Holck, A. L., Zhou, Y., & Liu, R. (2020) · ACS Omega · doi:10.1021/acsomega.9b04402 · Cited by 18
Savva, C., Helguero, L. A., Gonzalez-Granillo, M. A., Couto, D., Melo, T., Li, X., Angelin, B., Domingues, M. R., Kutter, C., & Korach-André, M. (2021) · Communications Biology · doi:10.1038/s42003-020-01513-z · Cited by 17
Analysis of the Sphingolipidome in NAFLD
Montefusco, D. J., Lambert, J. M., Anderson, A. K., Allegood, J. C., & Cowart, L. A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2128-8_22 · Cited by 17
Türkmen, K., Özer, H., & Kusztal, M. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051308 · Cited by 18
Effects of the Gut Microbiota and Barrier Function on Melatonin Efficacy in Alleviating Liver Injury
Zhang, H., Liu, X., Elsabagh, M., Zhang, Y., Ma, Y., Jin, Y., Wang, M., Wang, H., & Jiang, H. (2022) · Antioxidants · doi:10.3390/antiox11091727 · Cited by 16
“It has been indicated that ER stress exerts an important role in apoptosis and the aberrant lipid metabolism [39].”
BackgroundSphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis
Osawa, Y., Kawai, H., Nakashima, K., Nakaseko, Y., Suto, D., Yanagida, K., Hashidate‐Yoshida, T., Mori, T., Yoshio, S., Ohtake, T., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303296 · Cited by 17
Zhang, S., Zheng, S., Li, Y., Yang, J., Mao, X., Liu, T., Zhang, Q., Fu, Z., Zhu, X., & Xu, L. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23809 · Cited by 16
Bowman, E., Cameron, C., Richardson, B., Kulkarni, M., Gabriel, J., Kettelhut, A., Hornsby, L., Kwiek, J. J., Turner, A. N., Malvestutto, C., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01755-20 · Cited by 18
“Furthermore, HCERs (22:0, 24:0, and 24:1) were previously associated with hepatic inflammation and nonalcoholic steatohepatitis in obese adults (48), and we observed increased concentrations of these HCER species following PrEP initiation.”
[Prevalence and harm of nonalcoholic fatty liver disease].
Shao, Y., & Fan, J. (2019) · PubMed Central · doi:10.3760/cma.j.issn.1007-3418.2019.01.004 · Cited by 16
McCaffrey, J. M., & Ibdah, J. A. (2025) · Nutrients · doi:10.3390/nu17182972 · Cited by 19
“A separate study found an increase in hepatic total ceramide and DhCer (dihydroceramide) C16:0, 22:0, and 24:1 in individuals with NASH, regardless of whether they were categorized as lean or insulin-resistant obese [173].”
Characterization and Roles of Membrane Lipids in Fatty Liver Disease
Welch, M., Secunda, C., Ghimire, N., Martinez, I., Mathus, A., Patel, U., Bhogoju, S., Al‐Mutairi, M., Min, K., & Lawan, A. (2022) · Membranes · doi:10.3390/membranes12040410 · Cited by 18
“In recent years, there has been growing interest in the role of glycolipids, particularly sphingolipids, during NAFLD progression [56].”
BackgroundWolff, G., Sakurai, M., Mhamane, A., Troullinaki, M., Maida, A., Deligiannis, I. K., Yin, K., Weber, P., Morgenstern, J., Wieder, A., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101487 · Cited by 15
Self-citationSun, X., Qu, T., Wang, W., Li, C., Yang, X., He, X., Wang, Y., Xing, G., Xu, X., Yang, L., et al. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17026 · Cited by 18
A critical role for Phocaeicola vulgatus in negatively impacting metformin response in diabetes
Chen, M., Peng, Y., Hu, Y., Kang, Z., Chen, T., Zhang, Y., Chen, X., Li, Q., Yuan, Z., Wu, Y., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.02.008 · Cited by 15
Denimal, D., Béland‐Bonenfant, S., de Barros, J.-P. P., Rouland, A., Bouillet, B., Duvillard, L., Vergès, B. L., & Petit, J. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02049-2 · Cited by 15
“In contrast to our results, Apostolopoulou et al. found that the circulating levels of total ceramides were not significantly higher in obese individuals with biopsy-proven liver steatosis than in those without liver steatosis, but this study included only 7 individuals in each group [13].”
BackgroundResultInfluentialRein‐Fischboeck, L., Haberl, E. M., Pohl, R., Feder, S., Liebisch, G., Krautbauer, S., & Buechler, C. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1114-4 · Cited by 15
Little, R., Houghton, M. J., Carr, I., Wabitsch, M., Kerimi, A., & Williamson, G. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000034 · Cited by 15
The hypoglycemic activity of buckwheat and the underlying mechanisms: A mechanistic review
Jin, X., He, C., Guo, Z., Li, Y., Li, Y., Gao, J., Wang, M., & Han, L. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105046 · Cited by 13
Common Transcriptional Program of Liver Fibrosis in Mouse Genetic Models and Humans
Cokan, K. B., Urlep, Ž., Moškon, M., Mraz, M., Kong, X. Y., Eskild, W., Rozman, D., Juvan, P., & Režen, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020832 · Cited by 16
Zhu, M., Jia, Z., Yan, X., Liu, L., Fang, C., Feng, M., Dai, Y., Zhang, Y., Wu, H., Huang, B., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115427 · Cited by 13
Zhao, J., Zhou, Q., Liu, K., Li, P., Jiang, Y., & Li, H. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118922 · Cited by 16
Non‐alcoholic fatty liver disease in type 2 diabetes – A specific entity?
Schröder, B., KAHL, S., & Roden, M. (2021) · Liver International · doi:10.1111/liv.14846 · Cited by 13
“Assessment of hepatic mitochondrial oxidation and pyruvate cycling in NAFLD by (13)C magnetic resonance spectroscopy.”
BackgroundSelf-citationLiang, C., Li, J., Tian, B., Tian, L., Liu, Y., Li, J., Xin, L., Wang, J., Fu, C., Shi, Z., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112298 · Cited by 14
Heeba, G. H., El-Deen, R. M., Abdellatif, R., & Khalifa, M. M. A. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0487 · Cited by 12
“These results were in accordance with previous studies that highlighted 291 the role of increased insulin resistance in fatty liver development (Apostolopoulou et al. 2018; 292 Debes 2015).”
ResultWang, J., Zheng, J., Ren, X., Wang, S., Wang, G., Hu, B., Yang, H., & Liu, H. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13120 · Cited by 12
“Sphingolipid species are a group of compounds which are highly correlated with oxidative stress and inflammation in patients with NASH.(27) Among them, serum SM has been observed to increase in NASH mice.”
BackgroundChlorogenic Acid Inhibits Ceramide Accumulation to Restrain Hepatic Glucagon Response
Xiao, N., Zhang, T., Han, M., Tian, D., Liu, J., Li, S., Yang, L., & Pan, G. (2023) · Nutrients · doi:10.3390/nu15143173 · Cited by 12
“When the regulation of metabolic stresses caused by overnutrition does not function properly, many pro-inflammatory and inflammatory cytokines such as TNF, IL-6, and IL-1β are produced, which leads to the elevated glucose production and subsequent high blood glucose [13,15].”
BackgroundInfluentialSun, H., Pan, C., Yan, M., Wang, Z., He, J., Zhang, H., Yang, Z., Wang, Z., Wang, Y., Liu, H., et al. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.178219 · Cited by 11
Taltavull, N., Miralles‐Pérez, B., Nogués, M. R., Ramos‐Romero, S., Méndez, L., Medina, I., Torres, J. L., & Romeu, M. (2020) · Marine Drugs · doi:10.3390/md18060318 · Cited by 11
“Additionally, the activation of the salvage pathway may be positively associated with oxidative stress and inflammation in NASH conditions, suggesting that ceramide precursors contribute to the progression from fatty liver to NASH in humans [49].”
BackgroundBee products and diabetes mellitus
Maroof, K., & Gan, S. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85400-9.00012-5 · Cited by 11
Targeting Ceramides and Adiponectin Receptors in the Islet of Langerhans for Treating Diabetes
Li, W. (2022) · Molecules · doi:10.3390/molecules27186117 · Cited by 11
El-Deen, R. M., Heeba, G. H., Abdellatif, R., & Khalifa, M. M. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12530 · Cited by 11
Circulating metabolites and lipids are associated with glycaemic measures in South Asians
Gadgil, M. D., Kanaya, A. M., Sands, C. J., Lewis, M. R., Kandula, N. R., & Herrington, D. M. (2020) · Diabetic Medicine · doi:10.1111/dme.14494 · Cited by 11
“[33] In humans, lactosylceramides have been associated with non-alcoholic steatohepatitis in the context of insulin resistance.[34] In the current analysis, increases in LacCer(d18:1/16:0) and HexCer(d18:1/22:0) were inversely associated with odds of diabetes, while Cer(d16:1/20:0) was positively correlated with fasti…”
BackgroundThe role of glucosylceramide and glucosylceramide synthase in liver disease: from bench to bedside
Gan, J., Zheng, S. J., Mao, X. R., & Li, J. F. (2020) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5478 · Cited by 11
“Recently, the possible association between sphingolipids and liver diseases has become the focus of intense research (Apostolopoulou et al., 2018).”
BackgroundHeymann, C. J. F., Mak, A. L., Holleboom, A. G., Verheij, J., Shiri‐Sverdlov, R., van Mil, S. W. C., Tushuizen, M. E., Koek, G. H., & Grefhorst, A. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02380-x · Cited by 11
Dopamine D2 receptor signaling in the brain modulates circadian liver metabolomic profiles
Cervantes, M., Lewis, R. G., Fazia, M. A. D., Borrelli, E., & Sassone‐Corsi, P. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117113119 · Cited by 10
Umbilical Cord Plasma Lysophospholipids and Triacylglycerols Associated with Birthweight Percentiles
Wong, G., Narasimhan, K., Cheong, W. F., Ng, S., Aris, I. M., Loy, S. L., Bendt, A. K., Tan, K. H., Yap, F. K. P., Shek, L. P., et al. (2024) · Nutrients · doi:10.3390/nu16020274 · Cited by 9
“They have been associated with changes in maternal insulin resistance peripartum [32] and in adults [33], and implicated in hepatic insulin resistance [34].”
BackgroundMann, J. P., Lefere, S., Buytaert, M., Alisi, A., Arikan, C., Brecelj, J., Brown, R. M., Degrassi, I., Fiore, G., Fitzpatrick, E., et al. (2026) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70490 · Cited by 10
Analysis of Sphingolipids in Pediatric Patients with Cholelithiasis—A Preliminary Study
Zdanowicz, K., Bobrus‐Chociej, A., Pogodzińska, K., Błachnio-Zabielska, A. U., Żelazowska‐Rutkowska, B., Lebensztejn, D. M., & Daniluk, U. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195613 · Cited by 9
“On the other hand, a higher amount of liver C24:0-LacCer was observed in patients with non-alcoholic steatohepatitis (NASH) than in the controls [27].”
BackgroundHepatoprotective effect of Sophora m oorcroftiana (Benth.) Benth.Ex baker seeds in vivo and in vitro
Yuan, R., Dongzhi, Z., Guo, W., Zhen, P., Liu, Z., Huang, S., Li, B., & Yu, J. J. (2021) · Drug and Chemical Toxicology · doi:10.1080/01480545.2021.1962692 · Cited by 9
“SOD and GPx are important antioxidant enzymes in the body that can effectively remove free radicals and inhibit free radical-triggered lipid peroxidation (Apostolopoulou et al. 2018).”
BackgroundSong, Q., Liu, H., Zhang, Y., Qiao, C., & Ge, S. (2022) · ACS Omega · doi:10.1021/acsomega.2c00693 · Cited by 11
Yalcin, E. B., Tong, M., Cao, K., Huang, C., & de la Monte, S. M. (2023) · European Journal of Biology and Biotechnology · doi:10.24018/ejbio.2023.4.1.135 · Cited by 10
Hada, N., Katsume, A., Kenichi, K., Endo, C., Horiba, N., & Sudoh, M. (2023) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1094 · Cited by 11
“35-42 In addition, it has been shown that lipid oversupply increases the expression of sphingosine kinase (SphK), which phosphorylates sphingosine to produce S1P.”
Chatterjee, S. B., Zheng, L., Ma, S., Bedja, D., Bandaru, V. V. R., Kim, G., Rangecroft, A., Iocco, D., & Campbell, S. A. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.104 · Cited by 9
Rienzi, S. C. D., Johnson, E. L., Waters, J. L., Kennedy, E. A., Jacobson, J., Lawrence, P., Wang, D. H., Worgall, T. S., Brenna, J. T., & Ley, R. E. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108808 · Cited by 10
Siqueira, J. S., Palacio, T., Vieira, T. A., Nakandakare-Maia, E. T., Grandini, N. A., Ferron, A., Francisqueti-Ferron, F., & Corrêa, C. (2023) · Nutrire · doi:10.1186/s41110-023-00206-x · Cited by 6
Qi, Z., Le, S., Cheng, R., Du, X., Zhao, C., Zhang, Z., Zhang, X., Feng, L., Schumann, M., Mao, L., et al. (2024) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003388 · Cited by 8
“Interestingly, SM d18:1/18:0 was found to have the predictive effect for the AED group and was previously found to be the metabolite most associated with changes in insulin sensitivity (48).”
BackgroundAdipose tissue-derived metabolite risk scores and risk for type 2 diabetes in South Asians
Gadgil, M. D., Cheng, J. Q., Herrington, D. M., Kandula, N. R., & Kanaya, A. M. (2024) · International Journal of Obesity · doi:10.1038/s41366-023-01457-4 · Cited by 7
Metadata
- Authors
- Apostolopoulou, M., Gordillo, R., Koliaki, C., Gancheva, S., Jelenik, T., De Filippo, E., Herder, C., Markgraf, D., Jankowiak, F., Esposito, I., Schlensak, M., Scherer, P. E., & Roden, M.
- Affiliations
- Deutsches Diabetes-Zentrum e.V. (DE)
- The University of Texas Southwestern Medical Center (US)
- Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany
- Heinrich Heine University Düsseldorf (DE)
- Institute of Pathology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany
- Corresponding author
- Roden, Michael
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-03-30
- Volume
- 41
- Issue
- 6
- Pages
- 1235-1243
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2794512033
- Cited by
- 284
- References
- 37
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 41 · 2023: 33 · 2022: 46 · 2021: 35 · 2020: 50 · 2019: 31 · 2018: 10
- FWCI
- 24.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Research of the State of North Rhine-Westfalia
- German Federal Ministry of Health
- Federal Ministry for Research (BMBF) to the German Center for Diabetes Research
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, sphingolipids, ceramide, dihydroceramide, lactosylceramide, sphinganine, sphingomyelin, insulin resistance, hepatic insulin sensitivity, oxidative stress, lipid peroxidation, c-Jun N-terminal kinase, inflammation, mitochondrial function, obesity
- MeSH terms
- Adult, Animals, Female, Humans, Inflammation, Insulin Resistance, Liver, Male, Middle Aged, Obesity, Oxidation-Reduction, Prospective Studies, Sphingolipids, Lipid Peroxidation, Glucose Clamp Technique, Oxidative Stress, Disease Progression, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.